ИНВАЗИВНЫЕ СТОМАТОЛОГИЧЕСКИЕ ПРОЦЕДУРЫ У БОЛЬНЫХ, ПРИНИМАЮЩИХ ВАРФАРИН: ВОЗМОЖНОСТИ И ПЕРСПЕКТИВЫ БЕЗОПАСНОСТИ
https://doi.org/10.20996/1819-6446-2010-6-5-685-690
Аннотация
Обсуждаются особенности ведения больных, длительное время получающих лечение оральными антикоагулянтами (антивитаминами К) и нуждающихся в стоматологических вмешательствах. Дается оценка риска кровоточивости и возникновения тромбоэмболизма при периоперационном продолжении или прекращении приема варфарина. Уточняются возможности местных гемостатических препаратов. Предлагаются дополнения в карту здоровья стоматологического пациента с целью предупреждения осложнений, связанных с нарушениями свертывания крови.
Ключевые слова
Об авторах
Т. В. Козлова
Первый Московский Государственный Медицинский Университет им. И.М. Сеченова
Россия
Россия
д.м.н., доцент кафедры госпитальной терапии №1
119991, Москва, ул. Трубецкая, д. 8, стр. 2
И. М. Макеева
Первый Московский Государственный Медицинский Университет им. И.М. Сеченова
Россия
Россия
д.м.н., профессор, зав. кафедрой терапевтической стоматологии
119991, Москва, ул. Трубецкая, д. 8, стр. 2
В. Ю. Дорошина
Первый Московский Государственный Медицинский Университет им. И.М. Сеченова
Россия
Россия
к.м.н., доцент
119991, Москва, ул. Трубецкая, д. 8, стр. 2
С. И. Бокарева
Первый Московский Государственный Медицинский Университет им. И.М. Сеченова
Россия
Россия
студентка 5-го курса стоматологического факультета
119991, Москва, ул. Трубецкая, д. 8, стр. 2
Список литературы
1. Young K.M. Laboratory medicine: Yesterday, Today, Tomorrow. Vet Clin Path 2005; 34(1):76.
2. Singer D.E, Albers G., Dalen J.E. et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl):546S–592S.
3. Kearon C., Kahn S.R., Agnelli G. et al. Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 454S–545S.
4. Lim W., Wang M., Crowther M., Douketis J. The management of anticoagulated patients requiring dental extraction: a cross-sectional survey of oral and maxillofacial surgeons and hematologists. J Thromb Haemost 2007; 5(10):2157-9.
5. Linnebur S.A., Ellis S., Astroth J.D. Educational practices regarding anticoagulation and dental procedures in US dental schools. J Dent Educ 2007;71(2):296-303.
6. Ward B.B., SmithM.H.Dentoalveolar procedures forthe anticoagulated patient: literature recommendations versus current practice. J Oral Maxillofac Surg 2007; 65(8):1454-60.
7. Douketis J.D. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002; 108(1):3-13.
8. Dugdale M., Smith R.M. The patient with bleeding problems. Dent Clin North Am 1983;27(2): 271-88.
9. Patton L.L., Ship J.A. Treatment of patients with bleeding disorders. Dent Clin North Am 1994;38(3): 465-82.
10. Douketis J.D., Berger P.B., Dunn A.S. et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl):299S–339S.
11. Perry D.J., Noakes T.J., Helliwell P.S. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. British Dental Journal 2007; 203(7): 389-393.
12. Ziffer A.M., Scopp I.W., Beck J. et al. Profound bleeding after dental extractions during dicumarol therapy. N Engl J Med 1957; 256(8): 351-353.
13. Al-Mubarak S., Rass M.A.,Alsuwyed A. et al. Thromboembolic risk and bleeding in patients maintaining or stoppingoral anticoagulanttherapyduringdental extraction.J ThrombHaemost2006;4(3):689-691.
14. Randall C. Surgical management of the primary care dental patient on warfarin. Dent Update 2005; 32(7): 414-416, 419-420, 423-424.
15. Wahl M J. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158(15): 1610-1616.
16. Devani P., Lavery K.M., Howell C.J. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 1998; 36(2): 107-111.
17. Campbell J.H., Alvarado F., Murray R.A. Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered? J Oral Maxillofac Surg 2000; 58(2): 131-136.
18. Evans I.L., Sayers M.S., Gibbons A.J. et al. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2002; 40(3): 248-252.
19. Sacco R, Sacco M, Carpenedo M., Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006; 4(3): 688-689.
20. Nematullah A, Alabousi A, Blanas N. et al. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. Tex Dent J 2009;126(12):1183-93.
21. Sindet-Pedersen S. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: a pharmacokinetic study. J Clin Pharmacol 1987; 27(12): 1005-1008.
22. Blinder D., Manor Y., Martinowitz U. et al. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88(2): 137-140.
23. Blinder D., Manor Y., Martinowitz U., Taicher S. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 2001; 30(6): 518-521.
24. Zanon E., Martinelli F., Bacci C. et al. Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 2003; 14(1): 27-30.
25. Sindet-Pedersen S., Ramstrom G., Bernvil S., Blomback M.Hemostatic effect oftranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989; 320(13): 840-843.
26. Carter G., Goss A. Tranexamic acid mouthwash – a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 2003; 32(5): 504-507.
27. Stading J.A., Skrabal M.Z., FaulknerM.A. Seven cases ofinteraction betweenwarfarin and cyclooxygenase- 2 inhibitors. Am J Health Syst Pharm 2001;58(21):2076-2080.
28. Gould F.K., Elliott T.S., Foweraker J. et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57(6): 1035-1042.
29. Garcia D.A., Regan S., Henault L.E. et al. Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy. Arch Intern Med 2008;168(1):63-69
30. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 29 [Epub ahead of print].
31. Kovacs M.J., Kearon C., Rodger M. et al. Single-arm study of bridging therapy with low-molecularweight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110(12):1658-1663
32. Douketis J.D., Johnson J.A., Turpie A.G. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004;164(12): 1319-1326.
33. McBane R.D., Wysokinski W.E., Daniels P.R. et al. Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 2010;30(3):442-448.
34. Hong C.H., Napeñas J.J., Brennan M.T. et al. Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy. J Oral Maxillofac Surg. 2010;68(5): 975-9.
35. Murphy J., Twohig E., McWilliams S.R. Dentists' approach to patients on anti-platelet agents and warfarin: a survey of practice. J Ir Dent Assoc 2010;56(1):28-31.
36. Mehra P., CottrellD.A., Bestgen S.C., Booth D.F. Management of heparin therapy in the high-risk, chronically anticoagulated oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000;58(2):198-202.
Рецензия
Для цитирования:
Козлова Т.В., Макеева И.М., Дорошина В.Ю., Бокарева С.И. ИНВАЗИВНЫЕ СТОМАТОЛОГИЧЕСКИЕ ПРОЦЕДУРЫ У БОЛЬНЫХ, ПРИНИМАЮЩИХ ВАРФАРИН: ВОЗМОЖНОСТИ И ПЕРСПЕКТИВЫ БЕЗОПАСНОСТИ. Рациональная Фармакотерапия в Кардиологии. 2010;6(5):685-690. https://doi.org/10.20996/1819-6446-2010-6-5-685-690
For citation:
Kozlova T.V., Makeyeva I.M., Doroshina V.Y., Bokareva S.I. THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY. Rational Pharmacotherapy in Cardiology. 2010;6(5):685-690. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-5-685-690
Просмотров:
1024
Послать статью по эл. почте 